A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.
First patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism developed by the National Eye Institute
Lead author of the report, Doctor...
Researching DNA outside of our genes, analysing the ‘dark genome’, scientists have found evolved proteins which can distinguish between schizophrenia and bipolar disorders, improving diagnosis and treatment.
Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.
In toxicology & health science focus, Ken Tachibana, Sanyo-Onoda City University in Japan, walks through the long-term effects of exposure to nanoparticles
L. Val Giddings, PhD, Senior Fellow, Information Technology and Innovation Foundation, states that gene editing promises to make human industry sustainable*.
Pascale V Guillot from University College London, Elizabeth Garrett Anderson Institute for Women’s Health, explains stem cell and gene therapy to treat osteogenesis imperfecta, but is this hype or hope?
The study, published in PLoS Biology, looked at the neurotransmitter in the brain that calculates whether to pursue a task - in other words, motivation.
